Related Experiment Video

Updated: Mar 20, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Adult congenital heart disease: A paradigm of epidemiological change

Despοina Ntiloudi¹, George Giannakoulas¹, Despοina Parcharidou¹

¹First Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece.

International Journal of Cardiology

|May 31, 2016

Insights

Survival rates for congenital heart disease (CHD) patients have increased, but long-term complications and specialized care needs present ongoing challenges for lifelong medical surveillance and reproductive health.

Area of Science:

Cardiology
Adult Congenital Heart Disease (ACHD) care

Background:

Increasing survival rates in congenital heart disease (CHD) patients mark a significant medical advancement.
Despite progress, adult CHD patients face persistent long-term complications including arrhythmias, heart failure, and pulmonary hypertension.

Purpose of the Study:

To highlight the evolving challenges in managing adult congenital heart disease.
To emphasize the need for specialized reproductive counseling and obstetric care for women with CHD.
To underscore the growing demand for lifelong expert medical surveillance in cardiology.

Main Methods:

Review of current medical literature on adult congenital heart disease outcomes.
Analysis of healthcare utilization trends in CHD populations.
Synthesis of expert recommendations for lifelong CHD management.

Main Results:

Adult CHD survivors experience significant long-term morbidities requiring ongoing management.
A substantial proportion of CHD patients are women of childbearing age needing specialized reproductive care.
Healthcare utilization for CHD has increased, reflecting complex lifelong care requirements.

Conclusions:

Modern medicine has improved CHD survival, but comprehensive lifelong care is essential.
Specialized multidisciplinary care is crucial for managing complications and ensuring optimal health outcomes for adult CHD patients.
There is a growing need for integrated cardiology and reproductive services for the aging CHD population.

Read full analysis

Abstract:

Increasing survival rates for patients with congenital heart disease (CHD) represent a major achievement of modern medicine. Despite incredible progress been made in diagnosis, follow-up, early treatment and management in adulthood, many patients are faced with long-term complications, such as arrhythmia, thromboembolism, heart failure, pulmonary hypertension, endocarditis and/or the need for reoperation. In parallel, half of the patients are female, most of childbearing age, and, thus warrant specialist reproductive counseling and appropriate obstetric care. It is not surprising therefore, that healthcare utilization has steadily increased for CHD in recent years. Furthermore, cardiology and other medical disciplines are now faced with new challenges, namely the provision of expert care and optimal, lifelong medical surveillance for these patients.

Keywords:

Arrhythmia Congenital heart disease Epidemiology Heart failure Pregnancy Pulmonary hypertension

More Related Videos

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

Rheumatic Heart Disease I: Introduction

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Prevalence and Incidence

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...

Articles linked to this work by shared authors, journal, and citation graph.

Within a Heartbeat: A Machine Learning Approach Using VCG for Heart Failure Assessment in Sinus Rhythm.

Journal of personalized medicine·2026

The added value of echocardiography in pulmonary arterial hypertension risk assessment an artificial intelligence machine learning-derived analysis of the ULTRA RIGHT VALUE registry.

European heart journal. Cardiovascular Imaging·2026

Non-Invasive Assessment of Endothelial Dysfunction and Arterial Stiffness in Fontan Circulation.

European journal of clinical investigation·2026

Splenic Focused Ultrasound Improves Experimental Pulmonary Hypertension and Reprograms Immune Responses in Female and Male Rats.

Pulmonary circulation·2026

European Respiratory Society clinical practice guidelines update for the treatment of pulmonary arterial hypertension.

The European respiratory journal·2026

Predictive Power of Pulmonary Artery Stiffness-Right Ventricular Interplay, But Not Pulmonary Vascular Resistance, in Mild Pulmonary Hypertension: A PVRI GoDeep Meta-Registry Analysis.

Chest·2026

See all related articles